Coexistence of non-specific and usual interstitial pneumonia in a patient with severe cystic scleroderma lung involvement and parvovirus B19 infection.
Ghinoi
A
A
Mascia
M T
MT
Giuggioli
D
D
Magistro
R
R
Barbolini
G
G
Magro
C M
CM
Ferri
C
C
D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003560:Cysts / Q000150:complications* / Q000000981:diagnostic imaging / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D018192:Lymphangioleiomyomatosis / Q000175:diagnosis; D008775:Methylprednisolone / Q000627:therapeutic use; D010322:Parvoviridae Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D016732:Parvovirus B19, Human / Q000302:isolation & purification* / Q000472:pathogenicity; D013902:Radiography, Thoracic; D012595:Scleroderma, Systemic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone